Neil Andrews: Neil Andrews is a science journalist and editor based in New York City. With an undergraduate degree in neuroscience, and a graduate degree in science journalism from Boston University, he has over two decades of experience covering science and medicine for expert and non-expert audiences alike. Neil is currently the executive editor of AMD (The Association of Migraine Disorders)'s Migraine Science Collaborative (MSC), where he manages the day to day operations of the site, including its journalistic efforts and development of new web site features and programs. Previous to his current role, Neil was the executive editor of the Pain Research Forum.
Janelle Letzen: Dr. Janelle Letzen is a Health Science Policy Analyst in the Office of Pain Policy and Planning at the National Institute of Neurological Disorders and Stroke (NINDS). She completed her doctoral degree in Clinical Psychology at the University of Florida and her postdoctoral training in biobehavioral pain mechanisms at Johns Hopkins University (JHU). Prior to joining NINDS, Janelle held a faculty position for two years in the Department of Psychiatry & Behavioral Sciences at JHU where she conducted research on biopsychosocial mechanisms of chronic pain treatment responses, particularly among marginalized groups.
Candler Paige: Dr. Candler Paige is the Chief Executive Officer and co-founder of Doloromics. She received her doctorate in cognition and neuroscience from the University of Texas at Dallas where her work focused identifying sex-specific therapeutic targets. During her doctorate Candler received numerous awards including a DSPAN fellowship from the NIH. In 2020 Doloromics was spun-out from UT Dallas with Drs. Ted Price and Jackson Brougher. Since the founding, Candler has led Doloromics through the Illumina Accelerator, a team expansion, and the initiation of a drug discovery program. Prior to Doloromics, Candler received her B.S. in Biology and Neuroscience from the University of South Carolina and worked as a lab manager where she focused on gene therapies for chronic pain treatment.
Laura Wandner (guest speaker for the networking session only): Dr. Laura D. Wandner is a Program Officer in the Office of Pain Policy and Planning at the National Institute of Neurological Disorders and Stroke (NINDS). She manages programs within the Acute to Chronic Pain Signature Program (A2CPS) and the Helping to End Addiction Long-Term Initiative (HEAL).  She also leads the HEAL Initiative’s Common Data Element (CDE) initiative.  Dr. Wandner, a clinical health psychologist, continues to treat pain patients at Walter Reed National Military Medical Center (WRNMMC). Prior to joining NINDS, Dr. Wandner held the position of clinical pain psychologist at WRNMMC.  Dr. Wandner’s past research focused primarily on assessing how demographic characteristics impact providers’ pain management services; how patients and providers can use technology in pain.
Rui Li: Dr. Rui Li is a postdoctoral fellow at Seattle Children’s Research Institute. She received her PhD degree in Epidemiology from the University of Rochester and her bachelor’s degree in Preventive Medicine from Shanghai Jiao Tong University in China. Ser currently serves as the Co-Chair for the USASP Pain Epidemiology Special Interest Group (SIG) and is a past member of the USASP Education and Professional Development Committee.

Members can view a recording of this event here. 

Resources related to this seminar can be found here.